semaglutide sc PDB-101: Diabetes Mellitus: Diabetes Mellitus: undefined: STL Medical Weight Loss |

In this real-world setting, patients who were treated with semaglutide 2.4 mg and tirzepatide had a mean weight loss of 14.1% and 16.5% at 1 year, respectively, which represents a clinically meaningful weight loss with both therapies when used in patients with overweight or obesity and without T2DM [20]

One of the key dietary strategies is prioritizing protein

In our experience, a plant or whole foods-heavy diet with at least some consciousness around carbohydrates and varying degrees of intermittent fasting can maximize the effectiveness of the Semaglutide or Tirzepatide program

The data we have is reassuring but not complete

(2024, February 6)